BioLok gets FDA approval for nano product

Mar. 22, 2006 – BioLok International Inc. (OTC.BB: BLLI), a manufacturer and distributor of dental implant technology, received clearance from the U.S. Food and Drug Administration to market its nano-based product.

The nanocomposite, time-release calcium sulfate product is used for bone regeneration, augmentation and other dental applications. BioLok is headquartered in Deerfield Beach, Fla.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.